MARCHESINI, Sergio
 Distribuzione geografica
Continente #
NA - Nord America 2.104
EU - Europa 845
AS - Asia 494
AF - Africa 4
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.451
Nazione #
US - Stati Uniti d'America 2.097
CN - Cina 348
UA - Ucraina 261
DE - Germania 180
PL - Polonia 98
GB - Regno Unito 91
FI - Finlandia 80
HK - Hong Kong 73
IE - Irlanda 41
IT - Italia 30
IN - India 27
FR - Francia 17
IR - Iran 15
RU - Federazione Russa 15
SE - Svezia 13
BE - Belgio 11
SG - Singapore 10
TR - Turchia 10
CA - Canada 6
JP - Giappone 4
VN - Vietnam 4
AU - Australia 3
BD - Bangladesh 2
HU - Ungheria 2
RO - Romania 2
AL - Albania 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
KG - Kirghizistan 1
LT - Lituania 1
MU - Mauritius 1
PA - Panama 1
SC - Seychelles 1
Totale 3.451
Città #
Fairfield 309
Woodbridge 276
Jacksonville 201
Ashburn 145
Houston 138
Cambridge 134
Wilmington 133
Seattle 115
Ann Arbor 102
Warsaw 98
Chandler 94
Nanjing 80
Princeton 78
Hong Kong 70
Beijing 62
Lancaster 50
New York 43
Helsinki 42
Dublin 41
Dearborn 32
Nanchang 31
Shenyang 26
Hebei 20
Jinan 20
Des Moines 19
Tianjin 17
Kunming 15
Ardabil 14
Monmouth Junction 13
Brussels 11
Augusta 10
Leawood 10
Milan 9
San Diego 9
Jiaxing 8
Ningbo 8
San Francisco 8
San Mateo 8
Shanghai 8
Hangzhou 7
Kocaeli 7
Verona 7
Washington 7
Zhengzhou 7
Changsha 6
Haikou 6
Toronto 6
Lanzhou 5
Dong Ket 4
Guangzhou 4
Norwalk 4
Taizhou 4
Central 3
London 3
Lucknow 3
Nürnberg 3
Pune 3
Taiyuan 3
Boardman 2
Budapest 2
Changchun 2
Dhaka 2
Frankfurt am Main 2
Los Angeles 2
Melbourne 2
Modena 2
Bangalore 1
Berlin 1
Bishkek 1
Brescia 1
Cairo 1
Chicago 1
Dallas 1
Falkenstein 1
Fuzhou 1
Gamalero 1
Gunzenhausen 1
Hefei 1
Hounslow 1
Hyderabad 1
Izmir 1
Kilburn 1
Mahé 1
Minsk 1
Nanning 1
Oklahoma City 1
Paris 1
Phoenix 1
Redwood City 1
Sabz 1
Southwark 1
Sydney 1
Tallinn 1
Taranto 1
Timisoara 1
Tokyo 1
Tower Hamlets 1
Wuhan 1
Xian 1
Totale 2.648
Nome #
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 208
Uptake and metabolism of a fluorescent sulfatide analogue in cultured skin fibroblasts 146
Synthesis, spectral properties and enzymatic hydrolysis of fluorescent derivatives of cerebroside sulfate containing long-wavelength-emission probes 123
Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells. 109
The cytosolic sialidase Neu2 is degraded by autophagy during myoblast atrophy. 107
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures 106
Hypertrophy and atrophy inversely regulate Caveolin-3 expression in myoblasts 102
Cytosolic sialidase Neu2 upregulation during PC12 cells differentiation. 102
Beta-Galactosylceramidase deficiency: neurovascular implications 102
Phenotypic behavior of C2C12 myoblasts upon expression of the dystrophy-related caveolin-3 P104L and TFT mutants 101
Metabolic correction in oligodendrocytes derived from metachromatic leukodystrophy mouse model by using encapsulated recombinant myoblasts. 99
Defective myogenic differentiation of human rhabdomyosarcoma cells is characterized by sialidase Neu2 loss of expression. 98
Natural ceramide is unable to escape the lysosome, in contrast to a Fluorescent analogue 97
Ganglioside GM2 is substrate for a sialidase in MDCK cells 97
Cultured oligodendrocytes metabolize a fluorescent analogue of sulphatide; inhibition by monensin. 96
Nerve growth factor induces sphingomyelin accumulation in pheochromocytoma cells 96
Sulforhodamine GM1-ganglioside: synthesis and physico-chemical properties 95
Intracellular degradation of sulforhodamine-GM1: use for a fluorescence-based characterization of GM2-gangliosidosis variants in fibroblasts and white blood cells 92
Insulin-like growth factor 1 signaling regulates cytosolic sialidase Neu2 expression during myoblast differentiation and hypertrophy. 91
The enzymatic activity of sialidase Neu2 is inversely regulated during in vitro myoblast hypertrophy and atrophy. 90
Physico-chemical properties and metabolism of lissamine-rhodamine ceramides: effect of acyl chain length 89
Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells 87
Design and optimization of lentiviral vectors for transfer of galc expression in twitcher brain 86
Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice. 78
Oligodendroglial Progenitor Cell Therapy Limits Central Neurological Deficits in Mice with Metachromatic Leukodystrophy 76
Growth factors induce changes in ceramide metabolism in PC12 cells 73
In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice 68
Fluorescence-based diagnosis of lipid storage diseases by analysis of the culture medium of skin fibroblasts 67
Identification and characterization of a novel g-adaptin subunit in zebrafish 65
Intracellular vesicular traffic:cloning, expression and antisense inhibition of AP1m1 subunit ortholog in zebrafish 64
Lack of g-adaptin AP1 gene effects mouse development at early stage 62
IGF-I SIGNALING REGULATES CYTOSOLIC SIALIDASE NEU2 DURING MYOBLAST HYPERTROPHY. 61
A comparison study on the uptake and degradation of different fluorescent sulfatides by cultured skin fibroblasts 59
Involvment of sialidases in differentation of PC12 59
Intracellular vesicular traffic: identification and expression of zebrafihs APM1 during zebrafish development 57
IGF-I INDUCED HYPERTROPHY OF MYOBLASTS INCREASES CYTOSOLIC SIALIDASE NEU2 THROUGH PI-3 KINASE/AKT/mTOR PATHWAY. 57
Globoid cell leukodystrophy: inhibition of angiogenesis by beta-galactosylceramidase deficiency 56
HIGH RESIDUAL ARYLSULFATASE A (ARSA) ACTIVITY IN A PATIENT WITH LATE-INFANTILE METACHROMATIC LEUKODYSTROPHY 55
Inhibition of angiogenesis in Krabbe's disease: endothelial cytoskeleton disassembly by the glycosphingolipid psychosine 54
Utilizzazione di un probe fluorescente per lo studio del trasporto e del metabolismo dei solfatidi nel S.N.C. 52
Administration of a new fluorescent sulfatide into cultured cells for estimating arylsulfatase A deficiency 50
Metabolism of fluorescent sulfatides in cultured cells from controls and metachromatic leukodystrophy patients 34
Inhibition of sialidase activity by a 42 kDa protein from pig brain 3
Incorporazione di un derivato fluorescente del solfatide in fibroblasti di cute umana in coltura 1
Totale 3.570
Categoria #
all - tutte 15.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.005


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019220 0 0 0 0 0 0 0 0 0 0 108 112
2019/20201.044 136 33 38 128 56 118 107 110 75 149 37 57
2020/2021589 9 72 11 75 15 60 27 60 99 33 112 16
2021/2022385 30 80 3 12 1 11 23 14 24 69 36 82
2022/2023319 44 5 9 21 25 79 0 27 57 0 19 33
2023/2024312 25 8 50 20 26 72 14 7 82 8 0 0
Totale 3.570